Number one UFC middleweight contender Chael Sonnen is the center of MMA media attention this week as news broke Saturday night that the outspoken fighter had tested positive for steroids following his career-defining performance against UFC middleweight champion Anderson Silva this past August at UFC 117. It was revealed by the California State Athletic Commission that Sonnen failed his test for performance enhancing drugs due to abnormally high levels of testosterone in his urine sample. According to CSAC executive director George Dodd, Sonnen had indicated prior to his test that he was using a substance that could trigger a positive test result, though he never indicated any justifiable medical reason for taking any such substance. Sonnen’s manager, Mike Roberts, spoke with MMAJunkie.com today and revealed that his client, who has stayed uncharacteristically mum so far, will be appealing the failed test with the CSAC but was unable to offer much more information.
“It is our policy not to comment on pending actions by the athletic commission,” Roberts stated. “Chael is consulting with his legal [advisers] and physicians and will have a statement in the near future. Chael will file an appeal with the CSAC and looks forward to working with the commission to resolve this matter.”
“There’s not much else I can say at this point,” he added.
Dodd spoke with media earlier in the week and revealed that Sonnen will have thirty days to file his appeal, with the earliest his appeal could be heard being this December 2nd. Sonnen’s initial test was reexamined at the UCLA Olympic Analytical Laboratory after showing up positive for PEDs. No word yet on how this will affect his proposed rematch with Anderson Silva, which was likely to take place in early February. Should Sonnen’s appeal be turned down, he will face a $2,500 fine and a mandated year-long suspension.